TY - JOUR T1 - Analysis of SteraMist ionized hydrogen peroxide technology in the sterilization of N95 respirators and other PPE: a quality improvement study JF - medRxiv DO - 10.1101/2020.04.19.20069997 SP - 2020.04.19.20069997 AU - Avilash K. Cramer AU - Deborah Plana AU - Helen Yang AU - Mary M. Carmack AU - Enze Tian AU - Michael S. Sinha AU - David Krikorian AU - David Turner AU - Jinhan Mo AU - Ju Li AU - Rajiv Gupta AU - Heather Manning AU - Florence T. Bourgeois AU - Sherry H. Yu AU - Peter K. Sorger AU - Nicole R. LeBoeuf Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/08/2020.04.19.20069997.abstract N2 - Objective The COVID-19 pandemic has led to widespread shortages of personal protective equipment (PPE) for healthcare workers, including filtering facepiece respirators (FFRs) such as N95 masks. These masks are normally intended for single use, but their sterilization and subsequent reuse could substantially mitigate a world-wide shortage.Design Quality assurance.Setting A sealed environment chamber installed in the animal facility of an academic medical center.Interventions One to five sterilization cycles using ionized hydrogen peroxide (iHP), generated by SteraMist® equipment (TOMI; Frederick, MD).Main outcome measures Personal protective equipment, including five N95 mask models from three manufacturers, were evaluated for efficacy of sterilization following iHP treatment (measured with bacterial spores in standard biological indicator assemblies). Additionally, N95 masks were assessed for their ability to efficiently filter particles down to 0.3µm and for their ability to form an airtight seal using a quantitative fit test. Filtration efficiency was measured using ambient particulate matter at a university lab and an aerosolized NaCl challenge at a National Institute for Occupational Safety and Health (NIOSH) pre-certification laboratory.Results The data demonstrate that N95 masks sterilized using SteraMist iHP technology retain function up to five cycles, the maximum number tested to date. Some but not all PPE could also be sterilized using an iHP environmental chamber, but pre-treatment with a handheld iHP generator was required for semi-enclosed surfaces such as respirator hoses.Conclusions A typical iHP environment chamber with a volume of ~80 m3 can treat ~7000 masks per day, as well as other items of PPE, making this an effective approach for a busy medical center.Competing Interest StatementPKS is a member of the SAB or Board of Directors of Applied Biomath, Glencoe Software and RareCyte Inc and has equity in these companies. In the last five years the Sorger lab has received research funding from Novartis and Merck. Sorger declares that none of these relationships are directly or indirectly related to the content of this manuscript. NRB is a consultant for or has received honoraria from the following companies: Seattle Genetics, Sanofi, and Bayer. The authors have no affiliation with and received no compensation from TOMI Environmental Solutions, Inc and TOMI played no role in the design of the study. The authors corresponded with members of TOMI Corporation concerning the technical specifications of the SteraMist system.Funding StatementLocal citizens and engineers have generously donated their time and resources to PanFab and they are essential to program success. This work was supported by the Harvard-MIT Center for Regulatory Science and by NIH/NCI grants P30-CA006516, U54-CA225088 (to PKS, NL and DP) and by T32-GM007753 (to DP) and by the Harvard Ludwig Center. AKC is supported by the Hugh Hampton Young Fellowship of MIT.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available as supplementary materials. ER -